M&A / Deals Merck KGaA acquires JSR chromatography business Pharmaceutical TechnologyMerck KGaA has completed its previously announced acquisition of the chromatography business of JSR Life Sciences.M&A / DealsRead full story pharminent April 2, 2026 (Last updated: April 2, 2026) Pharmaceutical Technology Merck KGaA has completed its previously announced acquisition of the chromatography business of JSR Life Sciences. M&A / DealsRead full story Post navigation Previous: Alzheimer’s biotech Korsana to go public via reverse mergerNext: Threat of Trump’s pharma tariffs looms again Related Stories M&A / Deals Assertio accepts new buyout bid; AI biotech Isomorphic banks $2B pharminent May 13, 2026 M&A / Deals BMS, Hengrui build 13-asset pipeline in $15B+ onco-immune deal pharminent May 12, 2026 M&A / Deals Cellular Intelligence scoops up Novo’s Parkinson’s therapy pharminent May 12, 2026
